A recent analysis report conservatively estimates that in 2022 alone, out of 148 million people, the mass COVID-19 inoculations injured 26.6 million, disabled 1.36 million, and caused 300,000 excess deaths, with an estimated economic cost of nearly $150 billion.
The 2022 Vaccine Damage Report is a culmination of one year’s worth of data compiled by former Wall Street analyst Ed Dowd and his team at the research firm, Phinance Technologies. The report reveals the injuries, disabilities and deaths, or “human cost,” of the COVID-19 “vaccine” program in the United States for the year 2022. The research team focused their research on the 148 million employed Americans between the ages of 16 to 64.
Regarding full-time workers who had mild or moderate injuries that led to lower productivity at work, there was a 50 percent increase in lost worktime rates from 2019 to 2022, 28 percent increase in absence rates, and an estimated 26.6 million individuals affected.
Regarding disabilities of a civilian labor force aged 16-64, there was a 24.6 percent rise in disabilities since 2021 and an estimated 1.36 million individuals affected.
Regarding deaths for vaccine-related mortality in the population aged 25-64, there was a 23 percent excess mortality in 25-64 age groups, in 2021 and 2022 combined, and an estimated 300,000 excess deaths among people aged 25-64.
In summary, the Vaccine Damage Report reveals that out of the United States population of approximately 332 million people, the estimated human cost in 2022 was 26.6 million injuries, 1.36 million disabilities, and 300,000 excess deaths.
The report also states, “While these groupings characterize different levels of damage from the inoculations, they are not static and could interact with each other. For instance, there might be individuals who had no visible effects after vaccination but nonetheless could still be impacted from the inoculations and could therefore be represented in the sub-group of injured individuals. In a similar way, individuals with mild injuries from the inoculations could, over time, develop severe injuries to the extent of being disabled, or an extreme outcome such as death. The likely path of outcomes would be from injury to disability to death. We need to consider, however, that to a lesser extent there could be individuals who suffer extreme outcomes when they had previously only experienced mild injuries until then. We can relate this with the anecdotes of otherwise healthy athletes suffering heart attacks during sports competitions at an alarming rate since the 2021 inoculations.”
The research team analyzed the direct economic impact of the mass COVID-19 inoculations on individuals and computed only the direct amount of wages and salaries that were lost due to injuries (chronically sick), disabilities and excess deaths. The findings are that injuries from the COVID shot cost $89.9 billion and $52.2 billion for those with severe disabilities. Phinance computed excess deaths since 2021 for the 25 to 64 year-old demographic which amounted to $5.6 billion in lost productivity.
In summary, the researchers found a total economic cost of $147.8 billion in 2022 due to the COVID-19 shots.
Dowd stated, “Our economic damage estimates are what we can measure. The knock effects such as lost productivity due to a worker being present but working at say 50 percent -75 percent of capacity is missed plus burn out from those picking up slack. Also supply chain delays are not captured. The multiplier effects are massive.”
The researchers also noted, “The decision to accept a novel type of ‘vaccine’ and roll it out to mass populations in such a short timescale, is probably one of the most important of the current century. The fear in the population and the hope of a universal solution led populations to accept the novel ‘vaccines’ and then to accept the new technology as a platform for many other products. Pandora’s box was open and it is an obvious boon to the pharmaceutical industry. It was done with consent and even encouragement from the gatekeepers (governments, regulators, academia) and allied with a media campaign that reminded us of wartime.”
Dowd also calculated that since Pfizer and Moderna combined made $11.5 billion in revenues in the United States in 2022, every dollar they made cost the U.S. economy $13 dollars.
